Reply to: "Real-world experience of serial serum levels of GS-331007 in chronic hepatitis C hemodialysis patients during and after sofosbuvir/velpatasvir therapy"

J Hepatol. 2021 Oct;75(4):1007-1008. doi: 10.1016/j.jhep.2021.07.009. Epub 2021 Jul 19.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Carbamates
  • Hepatitis C, Chronic* / drug therapy
  • Heterocyclic Compounds, 4 or More Rings
  • Humans
  • Renal Dialysis
  • Sofosbuvir*

Substances

  • Carbamates
  • Heterocyclic Compounds, 4 or More Rings
  • velpatasvir
  • Sofosbuvir